Dimerix Limited (ASX:DXB)
Share Pricing & News Healthcare

AUD 0.17

0.015 (9.677%)
(As on 2022-12-01 20:55:49 AEDT)
Previous Close Open Close*
0.155 0.165 0.17
Market Cap Dividend Yield (Annualized)
AUD 54.549M 0.00%

Day Range
0.165L 0.17 H
52 WEEK HIGH LOW
0.12L 0.275 H

Chart Price & Information

Last Trade 0.17
Change% 9.6774
52 W H/L 0.275/0.120
EBITDA -16.906M
NPAT After Abnormal Items -10.491M
Equity 14.423M
ROE% -72.74%
Total Liabilities 2.074M
Total Revenue 6.463M
Cash and Cash Equivalents 9.63M

Stock Information

Share price 0.17
Market Cap 54.549M
Price/Gross Cash Flow -5.28
Dividend Yield Excluding Special 0.00%
Ending Shares 320.874M
52-Week Range 0.275-0.120
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.04
P/E ratio 0.000
Sector P/E --
EPS -3.56
EV/EBITDA --
Net Profit Margin (%) --
Gross Cash Flows Per Share -0.02
Net Gearing -66.26%
Sales Per Share 0.00
Book Value Per Share 0.04

Similar Companies

Related Articles

About Company

Dimerix Limited (ASX: DXB), is a clinical stage, biotechnology company that focusses on the development of new therapeutic treatments using its proprietary drug discovery platform, Receptor-Heteromer Investigation Technology (HIT).

Corporate Information


425 Smith Street, FITZROY, VIC, AUSTRALIA, 3065

Phone:+61 8 9388 8290

Website:http://www.dimerix.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-08-28 2023
Report (Prelim) 2023-08-28 2023
Report (Interim) 2023-02-23 2023